Anne L. Burkhardt - Concepedia

Concepedia

Author

Anne L. Burkhardt

Bristol-Myers Squibb (United States)

Also Known As

A Burkhardt, A L Burkhardt, A. Burkhardt, A. L. BURKHARDT, A. L. Burkhardt, A.L. Burkhardt, ANNE L. BURKHARDT, Anne Burkhardt, Anne L. Burkhardt

73

Publications

4.5K

Citations

31

H-Index

114

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Millennium Engineering and Integration (United States)University of Vermont National Cancer Institute

AL

About

Anne L. Burkhardt is an author at Bristol-Myers Squibb (United States) specializing in cell biology, medicine, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	32	3.4K
2	Natural Sciences	10	10	1.1K
3	Engineering	2	2	41
4	Health Sciences	1	1	14
5	Public Health	1	1	35

Anne L. Burkhardt

×

43

Publications

4.5K

Citations

31

H-Index

	Year	Citations
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ James E. Brownell, Michael D. Sintchak, James M. Gavin, Molecular Cell Protein ChemistryNedd8-amp MimeticProtein FunctionBiochemistryProtein Folding	2010	457
Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Anne L. Burkhardt, Mark Brunswick, Joseph B. Bolen, Proceedings of the National Academy of Sciences Adaptive Immune SystemImmunologyImmunologic MechanismSignaling PathwayReceptor Tyrosine Kinase	1991	423
Integral membrane protein 2 of Epstein—barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases Cheryl L. Miller, Anne L. Burkhardt, Jennifer H. Lee, Immunity Signal TransductionMolecular VirologyReceptor Tyrosine KinasePathogenesisImmunology	1995	320
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases Fatih M. Uckun, Evans We, C. J. Forsyth, Science	1995	275
Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Sandra J. Saouaf, S Mahajan, R. Rowley, Proceedings of the National Academy of Sciences Immune ActivationImmunologyAntigen ProcessingImmunotherapyReceptor Tyrosine Kinase	1994	246
Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. Mercedes Sanchez, Ziva Misulovin, Anne L. Burkhardt, The Journal of Experimental Medicine ImmunologyImmune RegulationCellular PhysiologyImmunogeneticsCa2+ Flux	1993	239
Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells S Yasumoto, Anne L. Burkhardt, Jay Doniger, Journal of Virology Viral ReplicationSynthetic VirologyPathologyMolecular BiologyDna Homology	1986	235
Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Seth J. Corey, Anne L. Burkhardt, Joseph B. Bolen, Proceedings of the National Academy of Sciences ImmunologyCellular PhysiologyThree-component ComplexInflammationSignaling Pathway	1994	213
Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. Peter A. Kiener, Bruce Rankin, Anne L. Burkhardt, Journal of Biological Chemistry Protein FunctionSignal TransductionSignaling PathwayMolecular PathwayReceptor Tyrosine Kinase	1993	195
Src Family Protein Tyrosine Kinases Induce Autoactivation of Bruton's Tyrosine Kinase Sandeep Mahajan, Joseph Fargnoli, Anne L. Burkhardt, Molecular and Cellular Biology Signal TransductionSignaling PathwayCell RegulationTyrosine 551Receptor Tyrosine Kinase	1995	150

Page 1